Offer - Urjas Oil for just ₹ 1 X
Krabeva is an allopathic medicine The correct dosage of Krabeva depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Krabeva is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Adult(Female) |
|
Geriatric |
|
Based on research, the following side effects have been observed when Krabeva is used -
Severe
Moderate
Mild
Common
Unknown
Is the use of Krabeva safe for pregnant women?
Is the use of Krabeva safe during breastfeeding?
What is the effect of Krabeva on the Kidneys?
What is the effect of Krabeva on the Liver?
What is the effect of Krabeva on the Heart?
Krabeva should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Krabeva unless your doctor advises you to do so -
Is this Krabeva habit forming or addictive?
Is it safe to drive or operate heavy machinery when consuming?
Is it safe?
Is it able to treat mental disorders?
Interaction between Food and Krabeva
Interaction between Alcohol and Krabeva
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 224-225
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 871
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avastin® (bevacizumab)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Avastin® (bevacizumab)